AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute.

@article{Smith2006AHAACCGF,
  title={AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute.},
  author={Sidney C. Smith and Jerilyn K Allen and Steven N. Blair and Robert O. Bonow and Lawrence M. Brass and G. Fonarow and Scott M. Grundy and Loren F. Hiratzka and Daniel W. Jones and Harlan M. Krumholz and Lori J. Mosca and Thomas A. Pearson and Marc A. Pfeffer and Kathryn A. Taubert},
  journal={Journal of the American College of Cardiology},
  year={2006},
  volume={47 10},
  pages={
          2130-9
        }
}

Tables from this paper

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.

The development of the present guideline involved a process of partial adaptation of other guideline statements and reports and supplemental literature searches, which confirmed that in patients with atherosclerotic vascular disease, comprehensive risk factor management reduces risk as assessed by a variety of outcomes.

2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

This work states that patient-specific modifiers, comorbidities, and issues of patient preference that might influence the choice of particular tests or therapies are considered, as well as frequency of follow-up and cost effectiveness.

Secondary prevention strategies for coronary heart disease

The epidemiology and risk assessment of CHD is discussed, current pharmacologic and nonpharmacologic strategies available for the secondary prevention ofCHD are summarized, and the guidelines and evidence that support these treatment options are summarized.

Non–ST segment elevation acute coronary syndromes: Treatment guidelines for the nurse practitioner

  • N. Albert
  • Medicine
    Journal of the American Academy of Nurse Practitioners
  • 2007
Familiarity with the patient as well as current management recommendations can improve clinical outcomes for patients with UA/NSTEMI, and NPs can play a pivotal role in the management of coronary disease, both during and following an acute ischemic event.

ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Compete

To address the expanding fund of knowledge in the area and to ensure that an adequately trained force of preventive cardiovascular leaders will be available to primary care healthcare providers, the formulation of clinical competency criteria for the cardiovascular preventive specialist is needed.

Diagnosis of Stable Ischemic Heart Disease: Summary of a Clinical Practice Guideline From the American College of Physicians/American College of Cardiology Foundation/American Heart Association/American Association for Thoracic Surgery/Preventive Cardiovascular Nurses Association/Society of Thoracic

This guideline grades the evidence and recommendations according to a translation of the ACCF/AHA grading system into ACP's clinical practice guidelines grading system and includes 28 recommendations that address the following issues: the initial diagnosis of the patient who might have stable ischemic heart disease, cardiac stress testing to assess the risk for death or myocardial infarction, and coronary angiography for risk assessment.

ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease

Revascularization in clinical scenarios with high symptom burden, high-risk features, and high coronary disease burden, as well as in patients receiving antianginal therapy, are deemed appropriate.

ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes

This update provides a reassessment of clinical scenarios that the writing group felt to be affected by significant changes in the medical literature or gaps from prior criteria, to provide a framework for the assessment of practice patterns that will hopefully improve physician decision making.

Identification of patients at risk of ischemic events for long‐term secondary prevention

  • A. Brassard
  • Medicine, Biology
    Journal of the American Academy of Nurse Practitioners
  • 2009
Patients at risk of secondary ischemic events are reviewed, the therapies available for their medical management are discussed, and the role of the nurse practitioner (NP) in their primary and long‐term care is identified.
...

References

SHOWING 1-10 OF 83 REFERENCES

AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology.

Since the original publication (in 1995) of the AHA consensus statement on secondary prevention, important evidence from clinical trials has emerged that further supports the merits of aggressive risk reduction therapies for patients with atherosclerotic cardiovascular disease.

ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients

These revised guidelines for the management of unstable angina and non–ST-segment elevation myocardial infarction were published in September 2000 and the present article describes these revisions and provides further updates in this rapidly moving field.

ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary article

These revised guidelines for the management of unstable angina and non–ST-segment elevation myocardial infarction were published in September 2000 and the present article describes these revisions and provides further updates in this rapidly moving field.

ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).

The major areas of change reflected in the update of the ACC/AHA Guidelines for Coronary Artery Bypass Graft Surgery are described in a format that can be read and understood as a stand-alone document.

Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

This statement from the American Heart Association and the National Heart, Lung, and Blood Institute is intended to provide up-to-date guidance for professionals on the diagnosis and management of the metabolic syndrome in adults.

Summary of the American Heart Association’s Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women

  • L. Mosca
  • Medicine
    Arteriosclerosis, thrombosis, and vascular biology
  • 2004
An expert panel was convened to establish evidence-based guidelines for the prevention of CVD in women and used an evidence rating system based on methods used in previous AHA/American College of Cardiology (ACC) guidelines.

Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.

The data demonstrate that weight loss and physical activity can prevent and treat obesity-related coronary heart disease risk factors and should be considered a primary therapy for obese patients with cardiovascular disease.
...